421 related articles for article (PubMed ID: 28428057)
1. Natural killer cells differentiated in vitro from cord blood CD34
Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
[TBL] [Abstract][Full Text] [Related]
2. Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells.
Domogala A; Madrigal JA; Saudemont A
Cytotherapy; 2016 Jun; 18(6):754-9. PubMed ID: 27090754
[TBL] [Abstract][Full Text] [Related]
3. Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.
Luevano M; Domogala A; Blundell M; Jackson N; Pedroza-Pacheco I; Derniame S; Escobedo-Cousin M; Querol S; Thrasher A; Madrigal A; Saudemont A
PLoS One; 2014; 9(1):e87086. PubMed ID: 24489840
[TBL] [Abstract][Full Text] [Related]
4. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
[TBL] [Abstract][Full Text] [Related]
5. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation.
Luevano M; Daryouzeh M; Alnabhan R; Querol S; Khakoo S; Madrigal A; Saudemont A
Hum Immunol; 2012 Mar; 73(3):248-57. PubMed ID: 22234167
[TBL] [Abstract][Full Text] [Related]
6. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
7. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
8. High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.
Veluchamy JP; Heeren AM; Spanholtz J; van Eendenburg JD; Heideman DA; Kenter GG; Verheul HM; van der Vliet HJ; Jordanova ES; de Gruijl TD
Cancer Immunol Immunother; 2017 Jan; 66(1):51-61. PubMed ID: 27783105
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture.
Tomchuck SL; Leung WH; Dallas MH
Biol Blood Marrow Transplant; 2015 Jan; 21(1):39-49. PubMed ID: 25464114
[TBL] [Abstract][Full Text] [Related]
11. Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.
Siegler U; Meyer-Monard S; Jörger S; Stern M; Tichelli A; Gratwohl A; Wodnar-Filipowicz A; Kalberer CP
Cytotherapy; 2010 Oct; 12(6):750-63. PubMed ID: 20491532
[TBL] [Abstract][Full Text] [Related]
12. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro.
Biswas BK; Guru SA; Sumi MP; Jamatia E; Gupta RK; Lali P; Konar BC; Saxena A; Mir R
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1595-1605. PubMed ID: 32592353
[TBL] [Abstract][Full Text] [Related]
15. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.
Lin SJ; Kuo ML
Pediatr Hematol Oncol; 2011 Nov; 28(8):640-6. PubMed ID: 21970456
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2.
Derniame S; Perazzo J; Lee F; Domogala A; Escobedo-Cousin M; Alnabhan R; Luevano M; Pedroza-Pacheco I; Cooper N; Madrigal A; Saudemont A
Cytotherapy; 2014 Oct; 16(10):1409-18. PubMed ID: 24969967
[TBL] [Abstract][Full Text] [Related]
18. Production of cytotoxic, KIR-negative NK cells from CD34+ cord blood cells with the use of Notch signaling.
Beck RC
Transfusion; 2011 Nov; 51 Suppl 4():145S-152S. PubMed ID: 22074625
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.
Lehmann D; Spanholtz J; Osl M; Tordoir M; Lipnik K; Bilban M; Schlechta B; Dolstra H; Hofer E
Stem Cells Dev; 2012 Nov; 21(16):2926-38. PubMed ID: 22571679
[TBL] [Abstract][Full Text] [Related]
20. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
